CO2021000763A2 - Estabilidad de la vitamina d en b-hidroxi- b-metilbutirato(hmb) - Google Patents

Estabilidad de la vitamina d en b-hidroxi- b-metilbutirato(hmb)

Info

Publication number
CO2021000763A2
CO2021000763A2 CONC2021/0000763A CO2021000763A CO2021000763A2 CO 2021000763 A2 CO2021000763 A2 CO 2021000763A2 CO 2021000763 A CO2021000763 A CO 2021000763A CO 2021000763 A2 CO2021000763 A2 CO 2021000763A2
Authority
CO
Colombia
Prior art keywords
vitamin
hmb
methylbutyrate
hydroxy
stability
Prior art date
Application number
CONC2021/0000763A
Other languages
English (en)
Inventor
John Rathmacher
Martin Purpura
Original Assignee
Metabolic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2019/038948 external-priority patent/WO2020263229A1/en
Application filed by Metabolic Tech Inc filed Critical Metabolic Tech Inc
Publication of CO2021000763A2 publication Critical patent/CO2021000763A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención proporciona una composición que comprende una formulación ácida que contiene P-hidroxi-P-metilbutirato (HMB), preferiblemente en la forma ácida libre, Vitamina D y un excipiente estabilizador, en donde la vitamina D se estabiliza contra la degradación.
CONC2021/0000763A 2018-06-25 2021-01-25 Estabilidad de la vitamina d en b-hidroxi- b-metilbutirato(hmb) CO2021000763A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862689305P 2018-06-25 2018-06-25
PCT/US2019/038948 WO2020263229A1 (en) 2019-06-25 2019-06-25 STABILITY OF VITAMIN D IN β-HYDROXY- β-METHYLBUTYRATE (HMB)

Publications (1)

Publication Number Publication Date
CO2021000763A2 true CO2021000763A2 (es) 2021-04-08

Family

ID=75293630

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2021/0000763A CO2021000763A2 (es) 2018-06-25 2021-01-25 Estabilidad de la vitamina d en b-hidroxi- b-metilbutirato(hmb)

Country Status (3)

Country Link
EP (1) EP3836803A4 (es)
BR (1) BR112020026621A2 (es)
CO (1) CO2021000763A2 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060019933A1 (en) * 2004-07-22 2006-01-26 David Boardman Process for preparing stabilized vitamin D
SG192692A1 (en) * 2011-02-07 2013-09-30 Abbott Lab Nutritional products comprising beta-hydroxy-beta-methylbutyrate
CN105578901A (zh) * 2014-03-14 2016-05-11 代谢科技有限公司 含有游离酸形式的β-羟基-β-甲基丁酸盐(HMB)的液体和食品

Also Published As

Publication number Publication date
EP3836803A4 (en) 2022-07-20
EP3836803A1 (en) 2021-06-23
BR112020026621A2 (pt) 2021-03-30

Similar Documents

Publication Publication Date Title
CL2019000586A1 (es) Composiciones de toxinas clostridiales no proteicas.
CR20170356A (es) Composiciones farmacéuticas para terapia combinada
AR088382A1 (es) Formulaciones de etanercept estabilizadas con xilitol
AR098168A1 (es) Formulación estable de insulina glulisina
CL2020002252A1 (es) Formulación oftálmica.
CL2016002560A1 (es) Forma de dosificación farmacéutica sólida oral que comprende siponimod, un agente protector de la humedad y opcionalmente un excipiente farmacéutico; procedimiento de preparación.
BR112019012099A2 (pt) composições e métodos de higiene bucal para branqueamento dos dentes
BR112018003617A2 (pt) adesivo não aquoso compreendendo lidocaína e método para administrar referido adesivo
BR112017004948A2 (pt) formulação farmacêutica.
CO2018007810A2 (es) Formulación líquida estable de gonadotropina
NI201900092A (es) Combinación farmacéutica que comprende ponesimod
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
BR112018012043A2 (pt) processo para a redução da transpiração
MX2018015965A (es) Composicion de dos componentes.
CL2021003065A1 (es) Formulaciones de terlipressina
CO2019000604A2 (es) Composición vaginal que comprende una combinación de estrógeno y vitamina d
MX2020004675A (es) Formulaciones de alcohol de seda.
CO2018010357A2 (es) Composiciones y métodos para estabilizar alfavirus con formulaciones mejoradas
CO2021000763A2 (es) Estabilidad de la vitamina d en b-hidroxi- b-metilbutirato(hmb)
CO2020003134A2 (es) Moduladores de la expresión de enac
CO2023000239A2 (es) Excipientes reductores de viscosidad y combinaciones de los mismos para formulaciones de proteína altamente concentradas
ECSP21079422A (es) Método para preparar formulaciones de péptidos estables
BR112018001793A2 (pt) preparação cosmética de redução do suor
ECSP20026436A (es) Métodos de uso y composiciones que contienen dulaglutida
CO2019007261A2 (es) Combinación de un inhibidor de mcl-1 y un compuesto taxano, usos y composiciones farmacéuticas de ésta